A fusion protein immunoconjugate of the extracellular domain of CTLA4 and the Fc domain of human IgG1. It functions as a T-cell co-stimulation blocker that inhibits TNF-ALPHA and prevents the activation of T-LYMPHOCYTES. It is used in the treatment of RHEUMATOID ARTHRITIS.
Belatacept — Orencia
CTLA-4-Ig — Cytotoxic T Lymphocyte-Associated Antigen 4-Immunoglobulin — Cytotoxic T Lymphocyte Associated Antigen 4 Immunoglobulin — CTLA4-Ig — CTLA4-Ig Immunoconjugate — CTLA4 Ig Immunoconjugate — Immunoconjugate, CTLA4-Ig — CTLA4-Fc — BMS224818 — BMS-224818 — BMS 224818 — Belatacept — Orencia — BMS 188667 — BMS-188667 — BMS188667 — LEA29Y — Nulojix